Universal API Implementation Guide
1.1.20 - ci-build
Universal API Implementation Guide - Local Development build (v1.1.20) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
No announcments for 6/14/24 release
The following Access Solutions/GPF questionnaires was removed:
| Available in Test Environment |
Product | linkId | Prescriber Form Version valid until: |
Comments |
|---|---|---|---|---|
| Yes | Actemra Intravenous Actemra Subcutaneous Rituxan for Immunology |
"linkId": "household-income" | No change to current Digital Consent fields | LinkId was replaced with "linkId": "household-income-amount" in Nov 2023 |
The following Access Solutions/GPF questionnaire was added:
Actemra (IV/Subcutaneous) and Rituxan for Immunology
| Available in Test Environment |
Product | linkId | Prescriber Form Version valid until: |
Comments |
|---|---|---|---|---|
| Yes | Actemra Intravenous Actemra Subcutaneous Rituxan for Immunology |
"linkId":"preferred-sp-optional" | No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |
linkId: preferred-sp-optional
{
"linkId": "preferred-sp-optional",
"text": "Preferred Specialty Pharmacy (Optional)",
"type": "string",
"enableWhen": [
{
"question": "applied-for-bipa",
"operator": "=",
"answerBoolean": true
},
{
"question": "sp-needed-for-rituxan-or-actemra",
"operator": "=",
"answerString": "yes"
}
],
"enableBehavior": "all",
"required": false,
"repeats": false
}
The following Access Solutions/GPF questionnaires were updated:
Actemra (IV/Subcutaneous) and Rituxan for Immunology
| Available in Test Environment |
Product | linkId | Description of Change | Update | Prescriber Form Version valid until: |
Comments |
|---|---|---|---|---|---|---|
| Yes | Actemra Intravenous Rituxan for Immunology |
"linkId": "pos" | "enableWhen" criteria updated to include Patient Foundation SR | enableWhen question": "applied-for-bipa = true question": "applied-for-appeals = true question": "applied-for-pf= true |
No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |
| Yes | Actemra Intravenous Rituxan for Immunology |
"linkId": "site-of-treatment" | questionnaire now 'required' | "required": true | No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |
| Yes | Actemra Intravenous Actemra Subcutaneous |
"linkId": "pa-in-place" | questionnaire now 'optional' | "required": false | No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |
| Yes | Actemra Intravenous Actemra Subcutaneous |
"linkId": "authorization" | questionnaire now 'optional' | "required": false | No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |
| Yes | Actemra Intravenous Actemra Subcutaneous Rituxan for Immunology |
"linkId": "actemra-intravenous-other-medicines-prescribed" "linkId": "actemra-subcutaneous-other-medicines-prescribed" "linkId": "rituxan-for-immunology-other-medicines-prescribed" |
questionnaire now 'required' | "required": true | No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |
| Yes | Actemra Subcutaneous | "linkId": "ship-to" | answerOptions updated to remove 'Site of Treatment' | Patient Prescriber Practice |
No change to current Rituxan/Actemra PSF (v2) | updated as part of questionnaire cleanup |